Nautilus Biotechnology, Inc. - stock earnings
NAUT Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -17.0 million USD | ? USD |
2023Q3 | -15.9 million USD | ? USD |
2023Q2 | -15.8 million USD | ? USD |
2023Q1 | -11.9 million USD | ? USD |
2022Q4 | -16.3 million USD | ? USD |
2022Q3 | -16.0 million USD | ? USD |
2022Q2 | -13.9 million USD | ? USD |
2022Q1 | -15.5 million USD | ? USD |
2021Q4 | -16.7 million USD | ? USD |
2021Q3 | -14.5 million USD | ? USD |
2021Q2 | -10.7 million USD | ? USD |
2021Q1 | -8.4 million USD | ? USD |
2020Q4 | -5.4 million USD | ? USD |
2020Q3 | -4.0 million USD | ? USD |
2020Q2 | -3.4 million USD | ? USD |
2020Q1 | -3.3 million USD | ? USD |
2019Q4 | 385490 USD | ? USD |
2019Q3 | 617205 USD | ? USD |
2019Q2 | 857162 USD | ? USD |
2019Q1 | 718765 USD | ? USD |
2018Q4 | 626.6 million USD | ? USD |
NAUT Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -63.7 million USD | ? USD |
2022 | -63.7 million USD | ? USD |
2021 | -50.3 million USD | ? USD |
2020 | -15.6 million USD | ? USD |
2019 | -9618 USD | ? USD |
2018 | 626.6 million USD | ? USD |
NAUT
Price: $2.69
52 week price:
Earnings Per Share: -0.51 USD
P/E Ratio: -5.87
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 189600
Market Capitalization: 346.5 million